Journal
LANCET
Volume 387, Issue 10027, Pages 1561-1572Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/S0140-6736(15)00241-X
Keywords
-
Categories
Funding
- Rio Hortega Contracts [CM12/00062]
- Juan Rodes Contracts (Instituto de Salud Carlos III, Spanish Ministry of Economy and Competiveness, Barcelona, Spain) [JR15/00012]
- NHMRC [1059660]
- Instituto de Salud Carlos III, Spanish Ministry of Economy and Competiveness, CIBERSAM [PI12/00912]
- Grups Consolidats de Recerca [SGR 398]
- Seventh European Framework Programme (ENBREC)
- Stanley Medical Research Institute
Ask authors/readers for more resources
Bipolar disorder is a recurrent chronic disorder characterised by fluctuations in mood state and energy. It affects more than 1% of the world's population irrespective of nationality, ethnic origin, or socioeconomic status. Bipolar disorder is one of the main causes of disability among young people, leading to cognitive and functional impairment and raised mortality, particularly death by suicide. A high prevalence of psychiatric and medical comorbidities is typical in affected individuals. Accurate diagnosis of bipolar disorder is difficult in clinical practice because onset is most commonly a depressive episode and looks similar to unipolar depression. Moreover, there are currently no valid biomarkers for the disorder. Therefore, the role of clinical assessment remains key. Detection of hypomanic periods and longitudinal assessment are crucial to differentiate bipolar disorder from other conditions. Current knowledge of the evolving pharmacological and psychological strategies in bipolar disorder is of utmost importance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available